Searched for
PFIZER BIONTECH EARNINGS
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer MetseraA fierce bidding war is underway for Metsera, an obesity drug developer. Novo Nordisk has made a $10 billion offer, which Metsera considers...- Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapyThe deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on expe...
- German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patentA German court has ruled that Pfizer and BioNTech violated Moderna's COVID-19 vaccine patent. The court in Duesseldorf stated that Pfizer a...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- Defensive sectors lift European shares after two-day rallyAfter jumping 3.8 per cent over the past two days, the region-wide STOXX 600 index nudged 0.1 per cent higher in early deals.
- Pfizer, BioNTech, Moderna making $1,000 profit every second: AnalysisThe Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a seco...
- AstraZeneca starts to make modest profit from Covid-19 vaccineThe Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...
- These are the stocks to watch as Covid enters its next phaseThe first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the...
- WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shotModerna said last October it would not enforce patents related to its shot during the pandemic, raising hopes that other companies might be...
- BioNTech says repeats of its COVID-19 vaccine better than devising new one, for nowThe German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns over wan...
- Moderna COVID-19 vaccine tallies more than $4 billion in Q2 salesModerna's announcement comes after pharmaceutical giant Pfizer Inc. said its COVID-19 vaccine remained effective months after the second do...
- Why big pharma had a responsibility to profit from the pandemicBig pharma companies like Pfizer and Moderna have profited immensely off the pandemic. However, questions arise as to whether or not this i...
- View: The first step to controlling the Covid surge is understanding where we went wrongTo get the required doses for India we need all the vaccines in the world we can get, foreign or domestic. Saying ‘why do we need foreign v...
- AstraZeneca says on track to deliver on Covid shots as sales hit $275 mnWhen including production and distribution from partners such as the Serum Institute of India, more than 300 million doses have been suppli...
- Market Movers: Pfizer soars on likely Covid vaccine nod; TCS sinks on profit bookingShares of Tata Motors jumped nearly 6 per cent after arm Jaguar Land Rover said that it is likely to report significant free cash flow in t...
- Pfizer sees $15 billion in 2021 sales from COVID-19 vaccinePfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...
- A stock trader’s guide to the global Covid vaccine rolloutThese are some of the sectors and stocks in traders’ sights for their roles in the global vaccine rollout.
- Hospitality sector boosts Tokyo stocks, stay-at-home winners lose footingInvestors switched to beaten-down value shares while dumping those which benefited from the stay-at-home trend during the pandemic, such as...
- European stocks gain on vaccine, stimulus hopes; earnings eyedThe pan-European STOXX index rose 1%, with miners gaining 1.7% on optimism over China's recovery and surging metal prices.
Load More
